WMSA
AMRI

Weiss Multi-Strategy Advisers’s Albany Molecular Research Inc AMRI Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-11,550
Closed -$116K – 1206
2013
Q4 		$116K Buy
+11,550
New +$140K ﹤0.01% 934

Other funds holding AMRI

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AMRI Position: Q1 2014 in Review

Weiss Multi-Strategy Advisers sold out of Albany Molecular Research Inc (AMRI) in Q1 2014, closing a stake of 11,550 shares — an estimated $116K sold.

Weiss Multi-Strategy Advisers first reported a position in AMRI in Q4 2013 and held it in 1 quarter. The position peaked at $116K in Q4 2013. 113 funds tracked by Wall St. Rank hold AMRI as of Q1 2014.

  • Weiss Multi-Strategy Advisers reported no remaining Albany Molecular Research Inc position as of Q1 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 11,550 Albany Molecular Research Inc shares in Q1 2014, an estimated $116K.
  • Weiss Multi-Strategy Advisers first reported a position in Albany Molecular Research Inc in Q4 2013 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Albany Molecular Research Inc position peaked at $116K in Q4 2013.
  • 113 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2014, filed 15 May 2014.